139 related articles for article (PubMed ID: 31583003)
21. Prognostic Utility of Cyclin D1 in Invasive Breast Carcinoma.
Parvin T; Das C; Choudhury M; Chattopadhyay BK; Mukhopadhyay M
Indian J Surg Oncol; 2019 Mar; 10(1):167-173. PubMed ID: 30948894
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of Rb, p16, Cyclin D1 proteins in soft tissue sarcomas.
Shim BY; Yoo J; Lee YS; Hong YS; Kim HK; Kang JH
Cancer Res Treat; 2010 Sep; 42(3):144-50. PubMed ID: 20948919
[TBL] [Abstract][Full Text] [Related]
23. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma.
Lu JW; Lin YM; Chang JG; Yeh KT; Chen RM; Tsai JJ; Su WW; Hu RM
Med Oncol; 2013 Mar; 30(1):379. PubMed ID: 23292829
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of p16(INK4A) and cyclin D1 in benign and malignant salivary gland tumors: a study of 44 Cases.
Jour G; West K; Ghali V; Shank D; Ephrem G; Wenig BM
Head Neck Pathol; 2013 Sep; 7(3):224-31. PubMed ID: 23315417
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 is a useful marker for soft tissue Ewing's sarcoma/peripheral Primitive Neuroectodermal Tumor in children and adolescents: A comparative immunohistochemical study with rhabdomyosarcoma.
Magro G; Brancato F; Musumeci G; Alaggio R; Parenti R; Salvatorelli L
Acta Histochem; 2015; 117(4-5):460-7. PubMed ID: 25765111
[TBL] [Abstract][Full Text] [Related]
26. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors.
Matsumura N; Nobusawa S; Ikota H; Hirato J; Hirose T; Yokoo H; Nakazato Y
Brain Tumor Pathol; 2015 Oct; 32(4):261-7. PubMed ID: 26233522
[TBL] [Abstract][Full Text] [Related]
27. Positive expression of cyclin D1 is an indicator for the evaluation of the prognosis of breast cancer.
Guo L; Liu S; Jakulin A; Yilamu D; Wang B; Yan J
Int J Clin Exp Med; 2015; 8(10):18656-64. PubMed ID: 26770479
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of cyclin D1 in ameloblastomas and adenomatoid odontogenic tumors.
Kumar H; Vandana R; Kumar G
J Oral Maxillofac Pathol; 2011 Sep; 15(3):283-7. PubMed ID: 22144830
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical evaluation of p63 and cyclin D1 in oral squamous cell carcinoma and leukoplakia.
Patel SB; Manjunatha BS; Shah V; Soni N; Sutariya R
J Korean Assoc Oral Maxillofac Surg; 2017 Oct; 43(5):324-330. PubMed ID: 29142867
[TBL] [Abstract][Full Text] [Related]
31. [Role of immunocytochemistry in fine needle aspiration cytology diagnosis of mammary lesions of breast].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):738-43. PubMed ID: 17374259
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
[TBL] [Abstract][Full Text] [Related]
33. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
[TBL] [Abstract][Full Text] [Related]
34. The validity of immunocytochemical expression of cyclin D1 in fine needle aspiration cytology of breast carcinoma.
Ezzat N; Hafez N
J Egypt Natl Canc Inst; 2012 Sep; 24(3):145-50. PubMed ID: 22929921
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
36. Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate.
Gupta V; Garg M; Chaudhry M; Singh S; Sen R; Gill M; Sangwaiya A
Prostate Int; 2014; 2(2):90-6. PubMed ID: 25032195
[TBL] [Abstract][Full Text] [Related]
37. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
Yang CC; Chu KC; Chen HY; Chen WC
Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
[TBL] [Abstract][Full Text] [Related]
38. The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas.
Lebe B; Sağol O; Ulukuş C; Coker A; Karademir S; Astarcioglu H; Küpelioğlu A; Astarcioğlu I; Obuz F
Pathol Res Pract; 2004; 200(5):389-96. PubMed ID: 15239347
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma.
Bassiouny AE; Nosseir MM; Zoheiry MK; Ameen NA; Abdel-Hadi AM; Ibrahim IM; Zada S; El-Deen AH; El-Bassiouni NE
World J Hepatol; 2010 Jan; 2(1):32-41. PubMed ID: 21160954
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors.
Huang X; Bai HM; Chen L; Li B; Lu YC
J Clin Neurosci; 2010 Dec; 17(12):1515-9. PubMed ID: 20863706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
